As of 2025-04-22, the Relative Valuation of Atossa Therapeutics Inc (ATOS) is (2.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.64 USD, the upside of Atossa Therapeutics Inc based on Relative Valuation is -517.2%.
The range of the Relative Valuation is (1.70) - (3.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 22.7x | 13.9x |
| Forward P/E multiples | 8.0x - 19.8x | 13.0x |
| Fair Price | (1.70) - (3.92) | (2.66) |
| Upside | -367.4% - -715.3% | -517.2% |
| Date | P/E |
| 2025-04-21 | -3.21 |
| 2025-04-17 | -3.16 |
| 2025-04-16 | -3.06 |
| 2025-04-15 | -3.16 |
| 2025-04-14 | -3.21 |
| 2025-04-11 | -3.27 |
| 2025-04-10 | -2.99 |
| 2025-04-09 | -3.14 |
| 2025-04-08 | -2.99 |
| 2025-04-07 | -3.28 |
| 2025-04-04 | -3.04 |
| 2025-04-03 | -3.25 |
| 2025-04-02 | -3.48 |
| 2025-04-01 | -3.30 |
| 2025-03-31 | -3.41 |
| 2025-03-28 | -3.53 |
| 2025-03-27 | -3.54 |
| 2025-03-26 | -3.53 |
| 2025-03-25 | -3.67 |
| 2025-03-24 | -3.79 |
| 2025-03-21 | -3.82 |
| 2025-03-20 | -3.62 |
| 2025-03-19 | -3.76 |
| 2025-03-18 | -3.67 |
| 2025-03-17 | -3.70 |
| 2025-03-14 | -3.65 |
| 2025-03-13 | -3.47 |
| 2025-03-12 | -3.63 |
| 2025-03-11 | -3.75 |
| 2025-03-10 | -3.75 |
| 2025-03-07 | -3.74 |
| 2025-03-06 | -3.80 |
| 2025-03-05 | -3.76 |
| 2025-03-04 | -3.71 |
| 2025-03-03 | -3.75 |
| 2025-02-28 | -3.88 |
| 2025-02-27 | -3.77 |
| 2025-02-26 | -3.90 |
| 2025-02-25 | -3.82 |
| 2025-02-24 | -3.97 |
| 2025-02-21 | -4.03 |
| 2025-02-20 | -4.25 |
| 2025-02-19 | -4.45 |
| 2025-02-18 | -4.24 |
| 2025-02-14 | -4.20 |
| 2025-02-13 | -4.13 |
| 2025-02-12 | -3.89 |
| 2025-02-11 | -3.94 |
| 2025-02-10 | -4.15 |
| 2025-02-07 | -3.88 |